BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in
these cases for the first and second line is not clear. An international registry was created for …

Dermatomyositis is a rare inflammatory myopathy that is often related to lung cancer. In this
retrospective observational study, we analyzed data from patients diagnosed with lung …

The diagnosis of thyroid cancer (TC) has increased dramatically in recent years. Papillary
TC is the most frequent type and has shown good prognosis. Conventional treatments for TC …

Immune checkpoint inhibitors (ICIs), pembrolizumab in particular, have been shown to be
vastly more efficacious than traditional cytotoxic or platinum-based chemotherapies in the …

Immune checkpoint inhibitors have become the standard of care in the treatment of
metastatic non-small-cell lung cancer (NSCLC). The combination of nivolumab plus …

In this particular case study, we present a 66-year-old male who was diagnosed with an
atrial myxoma eight years after receiving treatment for non-small cell lung cancer. The …

Amplification of the mesenchymal epithelial transition (MET) gene is a mechanism of
acquired resistance to epidermal growth factor receptor (EGFR)-tyrosine-kinase-inhibitors …

Introduction Many data already suggested that cancer and IPF are underlined by a number
of common pathogenic biologic pathways. However, fewer data regards the …

Simple Summary This study focused on immune checkpoint inhibitor therapy effectiveness
in patients with non-small cell lung cancer (NSCLC), particularly concerning programmed …

Patient prognoses have been significantly enhanced by immune checkpoint inhibitors (ICIs),
altering the standard of care in cancer treatment. These novel antibodies have become a …